FEB 24, 2016 09:00 AM PST

Keynote Presentation - Progress in the Precision Medicine Initiative

C.E. CREDITS: P.A.C.E. CE
Speakers
  • Deputy Director for Science, Outreach and Policy, NIH
    Biography
      Kathy L. Hudson, Ph.D., is the Deputy Director for Science, Outreach, and Policy at the National Institutes of Health (NIH). Dr. Hudson leads the science policy, legislation, communication, and outreach efforts of the NIH and serves as a senior advisor to the NIH director. She is responsible for creating major new strategic and scientific initiatives for NIH and is currently leading the planning and creation of the President's Precision Medicine Initiative Cohort Program. Dr. Hudson was a key architect of the National Center for Advancing Translational Sciences and the NIH BRAIN Initiative. She directs the agency's efforts to advance biomedical research through policy development, public and stakeholder communication and education, and innovative projects and partnerships.

      Dr. Hudson's professional experience includes serving as the NIH Chief of Staff; Acting Deputy Director of the National Center for Advancing Translational Sciences, NIH; the Assistant Director of the National Human Genome Research Institute, NIH; and the founder and Director of the Genetics and Public Policy Center at John Hopkins University. Also at Hopkins, Dr. Hudson was an Associate Professor in the Berman Institute of Bioethics, Institute of Genetic Medicine, and Department of Pediatrics.

      Dr. Hudson holds a Ph.D. in Molecular Biology from the University of California at Berkeley, an M.S. in Microbiology from the University of Chicago, and a B.A. in Biology from Carleton College.

    Abstract:

    On January 20, 2015, President Obama announced the Precision Medicine Initiative® (PMI) (link is external) in his State of the Union address. Through advances in research, technology and policies that empower patients, the PMI will enable a new era of medicine in which researchers, providers and patients work together to develop individualized care.  This presentation will introduce the President’s PMI and provide an in-depth discussion of its key research component: the PMI Cohort Program.   With its aim to enroll 1 million or more U.S. volunteers representing the rich diversity of America, and to longitudinally collect EHR, environmental, genetic, and behavioral data, the PMI Cohort promises to change the face of precision medicine and generate results that will transform prevention and treatment for millions of Americans. 
     
    Learning objective:

    • Participants will understand the goals of the President’s Precision Medicine Initiative® (PMI) and implementation for the PMI Cohort Program.

    Show Resources
    You May Also Like
    MAY 22, 2018 08:00 AM PDT
    C.E. CREDITS
    MAY 22, 2018 08:00 AM PDT
    DATE: May 22, 2018TIME: 08:00AM PDT The nuclear receptors pregnane X receptor (PXR) and constitutive androstane receptor (CAR) are closely related transcription factors that...
    MAY 24, 2018 09:30 AM PDT
    C.E. CREDITS
    MAY 24, 2018 09:30 AM PDT
    DATE: May 24, 2018 TIME: 9:30PM PDT The current gold standard in in vitro pre-clinical cancer treatment screening remain cell lines,...
    MAY 03, 2018 11:00 AM PDT
    MAY 03, 2018 11:00 AM PDT
    DATE: May 3, 2018TIME: 11:00AM PDT, 2:00PM EDTWhile stress is one of the leading causes of neuropsychiatric disorders, the molecular underpinnings of how stress induces alterations in b...
    APR 27, 2018 10:00 AM PDT
    C.E. CREDITS
    APR 27, 2018 10:00 AM PDT
    DATE: April 27, 2018TIME: 10:00am PST, 1:00pm ESTGlioblastoma (GBM) and Medulloblastoma (MB) are the most common adult and paediatric brain tumours, both of which can have devastating c...
    MAY 02, 2018 08:00 AM PDT
    C.E. CREDITS
    MAY 02, 2018 08:00 AM PDT
    Immunohistochemistry protocols, which utilize antibodies to visualize proteins in tissue sections, have many steps that need optimized to prevent non-specific background effects, artifacts, o...
    AUG 15, 2018 08:00 AM PDT
    C.E. CREDITS
    AUG 15, 2018 08:00 AM PDT
    DATE: August 15, 2018TIME: 08:00AM PDT, 11:00AM EDTThe failure of current chemotherapeutic strategies in the fight against cancer can be largely attributed to the occurrence of drug res...
    Loading Comments...
    Show Resources